Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
- Posted on February 8, 2026
- By Google News
- 2 Views
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
